Off-Label Megestrol in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments

Am J Med. 2018 Jun;131(6):623-629.e1. doi: 10.1016/j.amjmed.2017.12.028. Epub 2018 Mar 6.

Authors

Jose M Garcia¹, Tatyana A Shamliyan²

Affiliations

¹ Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington School of Medicine, Seattle, Wash; Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Wash.
² Quality Assurance, Evidence-Based Medicine Center, Elsevier, Philadelphia, Pa. Electronic address: t.shamliyan@elsevier.com.

PMID: 29784194
DOI: 10.1016/j.amjmed.2017.12.028

No abstract available

Publication types

Systematic Review

MeSH terms

Adult
Anorexia / drug therapy*
Anorexia / etiology
Antineoplastic Agents, Hormonal / adverse effects
Antineoplastic Agents, Hormonal / therapeutic use
Cachexia / drug therapy*
Cachexia / etiology
Child
Humans
Megestrol / adverse effects
Megestrol / therapeutic use*
Neoplasms / complications*
Off-Label Use*

Substances

Antineoplastic Agents, Hormonal
Megestrol